Ellen L. Goode

28.4k total citations · 1 hit paper
148 papers, 6.0k citations indexed

About

Ellen L. Goode is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Ellen L. Goode has authored 148 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 61 papers in Genetics and 56 papers in Cancer Research. Recurrent topics in Ellen L. Goode's work include Ovarian cancer diagnosis and treatment (47 papers), Cancer-related molecular mechanisms research (35 papers) and Genetic Associations and Epidemiology (30 papers). Ellen L. Goode is often cited by papers focused on Ovarian cancer diagnosis and treatment (47 papers), Cancer-related molecular mechanisms research (35 papers) and Genetic Associations and Epidemiology (30 papers). Ellen L. Goode collaborates with scholars based in United States, United Kingdom and Australia. Ellen L. Goode's co-authors include Cornelia M. Ulrich, John D. Potter, Kimberly R. Kalli, Lynn C. Hartmann, Keith L. Knutson, Julie M. Cunningham, Gail P. Jarvik, Brooke L. Fridley, Chen Wang and Robert A. Vierkant and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and The Journal of Immunology.

In The Last Decade

Ellen L. Goode

147 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polymorphisms in DNA repair genes and associations with cancer risk.

2002 1.0k citations Ellen L. Goode, Cornelia M. Ulrich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellen L. Goode United States	40	3.1k	1.7k	1.6k	1.4k	903	148	6.0k
Amir A. Jazaeri United States	34	2.6k 0.8×	2.3k 1.4×	1.8k 1.1×	858 0.6×	775 0.9×	169	5.7k
Johnathan M. Lancaster United States	34	2.7k 0.9×	1.2k 0.7×	1.6k 1.0×	1.1k 0.8×	1.3k 1.5×	98	5.4k
Yinhua Yu United States	42	3.8k 1.2×	1.2k 0.7×	1.1k 0.7×	790 0.6×	1.0k 1.2×	82	5.8k
Shigehira Saji Japan	39	2.3k 0.8×	3.9k 2.3×	1.8k 1.1×	2.3k 1.6×	308 0.3×	252	7.2k
Christina M. Annunziata United States	37	2.5k 0.8×	2.6k 1.6×	1.0k 0.6×	457 0.3×	1.1k 1.2×	155	5.4k
Carl Morrison United States	45	4.2k 1.4×	2.3k 1.4×	2.4k 1.5×	865 0.6×	272 0.3×	185	8.1k
Steffen Hauptmann Germany	42	2.1k 0.7×	1.4k 0.8×	1.0k 0.6×	523 0.4×	623 0.7×	111	4.9k
Seiji Mabuchi Japan	42	2.4k 0.8×	1.6k 1.0×	1.1k 0.7×	317 0.2×	1.5k 1.6×	192	5.7k
Aikou Okamoto Japan	36	4.4k 1.4×	1.9k 1.1×	3.1k 1.9×	347 0.3×	1.7k 1.8×	267	8.0k
Sacha J. Howell United Kingdom	35	1.7k 0.5×	2.1k 1.2×	1.0k 0.6×	886 0.6×	401 0.4×	146	4.4k

Countries citing papers authored by Ellen L. Goode

Since Specialization

Citations

This map shows the geographic impact of Ellen L. Goode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen L. Goode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen L. Goode more than expected).

Fields of papers citing papers by Ellen L. Goode

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen L. Goode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen L. Goode. The network helps show where Ellen L. Goode may publish in the future.

Co-authorship network of co-authors of Ellen L. Goode

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen L. Goode. A scholar is included among the top collaborators of Ellen L. Goode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen L. Goode. Ellen L. Goode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Na, Renhua, Kathryn Alsop, Ellen L. Goode, et al.. (2024). Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis. Cancer Epidemiology Biomarkers & Prevention. 33(4). 586–592. 2 indexed citations

Zhang, Xianyang, et al.. (2023). Batch-effect correction with sample remeasurement in highly confounded case-control studies. Nature Computational Science. 3(8). 709–719. 4 indexed citations

Nakamura, Koji, Brett M. Reid, Ann Chen, et al.. (2021). Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer. The American Journal of Human Genetics. 109(1). 116–135. 7 indexed citations

Herschtal, Alan, Brad H. Nelson, Anna DeFazio, et al.. (2019). Going to extremes: determinants of extraordinary response and survival in patients with cancer. Nature reviews. Cancer. 19(6). 339–348. 24 indexed citations

Liu, Yuanhang, Pritha Chanana, Jaime Davila, et al.. (2019). Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts. Scientific Reports. 9(1). 6314–6314. 32 indexed citations

Yang, Haitao, et al.. (2019). Testing Mediation Effects in High-Dimensional Epigenetic Studies. Frontiers in Genetics. 10. 1195–1195. 30 indexed citations

Li, Qian, Janelle Noel‐MacDonnell, Devin C. Koestler, Ellen L. Goode, & Brooke L. Fridley. (2018). Subject level clustering using a negative binomial model for small transcriptomic studies. BMC Bioinformatics. 19(1). 474–474. 6 indexed citations

Wang, Chen, Sebastian M. Armasu, Kimberly R. Kalli, et al.. (2017). Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes. Clinical Cancer Research. 23(15). 4077–4085. 65 indexed citations

Lamichhane, Purushottam, Lavakumar Karyampudi, Barath Shreeder, et al.. (2017). IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer. Cancer Research. 77(23). 6667–6678. 122 indexed citations

10.

Tóth, Réka, Dominique Scherer, Linda E. Kelemen, et al.. (2017). Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium. Cancer Epidemiology Biomarkers & Prevention. 26(6). 816–825. 11 indexed citations

11.

Way, Gregory P., Chen Wang, Habib Hamidi, et al.. (2016). Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes. G3 Genes Genomes Genetics. 6(12). 4097–4103. 26 indexed citations

12.

Raghavan, Rama, Stephen Hyter, Harsh B. Pathak, et al.. (2016). Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer. BMC Genomics. 17(1). 811–811. 21 indexed citations

13.

Karyampudi, Lavakumar, Purushottam Lamichhane, James Krempski, et al.. (2015). PD-1 Blunts the Function of Ovarian Tumor–Infiltrating Dendritic Cells by Inactivating NF-κB. Cancer Research. 76(2). 239–250. 86 indexed citations

14.

Hendrickson, Andrea E. Wahner, Kieran Hawthorne, Ellen L. Goode, et al.. (2015). Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic. Gynecologic Oncology. 137(1). 77–85. 16 indexed citations

15.

Cicek, Mine S., Matthew J. Maurer, & Ellen L. Goode. (2013). Survival Prediction Based on Inherited Gene Variation Analysis. Methods in molecular biology. 1049. 53–64. 1 indexed citations

16.

Stevens, Kristen N., Linda E. Kelemen, Xianshu Wang, et al.. (2012). Common Variation in Nemo-Like Kinase Is Associated with Risk of Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 21(3). 523–528. 8 indexed citations

17.

Kelemen, Linda E., Thomas A. Sellers, Joellen M. Schildkraut, et al.. (2008). Genetic Variation in the One-Carbon Transfer Pathway and Ovarian Cancer Risk. Cancer Research. 68(7). 2498–2506. 50 indexed citations

18.

Atkinson, Elizabeth J., Brooke L. Fridley, Ellen L. Goode, et al.. (2007). Linkage analysis using principal components of gene expression data. BMC Proceedings. 1(S1). S79–S79. 1 indexed citations

19.

Potter, John D., Ellen L. Goode, & Libby M. Morimoto. (2003). AACR Special Conference. Cancer Epidemiology and Prevention Biomarkers. 12(8). 803–805. 1 indexed citations

20.

Saccone, Nancy L., Ellen L. Goode, & Andrew W. Bergen. (2003). Genetic analysis workshop 13: Summary of analyses of alcohol and cigarette use phenotypes in the Framingham Heart Study. Genetic Epidemiology. 25(S1). S90–S97. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact